FDA News Digest March 10, 2003 ________________________________________________________________ FDA Proposal Would Require New Standards for Dietary Supplements FDA has proposed a rule that would, for the first time, establish standards to ensure that dietary supplements do not contain contaminants or impurities, and that product ingredients are listed accurately. Among the proposals are requirements for design of physical plants, quality control procedures, product testing, maintaining records, and handling consumer complaints. Press release: http://www.fda.gov/bbs/topics/NEWS/2003/NEW00876.html Fact sheet: http://www.fda.gov/bbs/topics/NEWS/dietarysupp/factsheet.html Backgrounder: http://www.fda.gov/bbs/topics/NEWS/dietarysupp/background.html ________________________________________________________________ FDA Offers Veterinary Science Publications Online in Spanish A new FDA website containing Spanish versions of six veterinary science publications is now online. Among the materials are two fact sheets explaining FDA's role in safeguarding animal health to protect consumers and keeping the United States free of bovine spongiform encephalopathy ("mad cow disease"). Also included are four compliance guides related to FDA's ruminant feed rules. http://www.fda.gov/cvm/index/spanish_pubs/CVMEspanol.htm ________________________________________________________________ RECALLS The following products have been recalled for the reasons shown. Go to the linked page for more information: Allied Import Inc. Chinese Candy (undeclared sulfates) -- http://www.fda.gov/oc/po/firmrecalls/allied02_03.html Galil Brand Sun-Dried Tomatoes in Oil (undeclared sulfates) -- http://www.fda.gov/oc/po/firmrecalls/galil03_03.html ________________________________________________________________ PUBLIC MEETINGS April Workshop to Discuss Risk Management for Drugs, Biologics FDA will sponsor a public workshop April 9-11 in Washington, D.C., to present the agency's current thoughts on risk management for drug and biologic products (excluding blood products other than plasma derivatives) and to solicit public opinions on the subject. http://www.fda.gov/cder/meeting/riskManagement.htm For a list of upcoming FDA meetings, seminars, and other public events, go to http://www.fda.gov/opacom/hpmeetings.html. ________________________________________________________________ Thanks for subscribing to the FDA News Digest. Our next posting will be March 17. To leave this list at any time, send an e-mail to LISTSERV@xxxxxxxxxxxx In the body of the message, write SIGNOFF FDA-NEWSDIGEST-L
